| Year |
Citation |
Score |
| 2020 |
Kober DL, Stuchell-Brereton MD, Kluender CE, Dean HB, Strickland MR, Steinberg DF, Nelson SS, Baban B, Holtzman DM, Frieden C, Alexander-Brett J, Roberson ED, Song Y, Brett TJ. Functional insights from biophysical study of TREM2 interactions with apoE and Aβ. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33090700 DOI: 10.1002/alz.12194 |
0.58 |
|
| 2019 |
Kober D, Kluender C, Brett T. P4-172: BIOPHYSICAL INVESTIGATION OF THE TREM2 INTERACTIONS WITH APOE AND AMYLOID BETA1-42
REVEAL TWO DISTINCT BINDING SURFACES AND A POTENTIAL ROLE FOR STREM2 AS AN INHIBITOR OF AMYLOID BETA1-42
POLYMERIZATION Alzheimer's & Dementia. 15: P1340-P1340. DOI: 10.1016/J.Jalz.2019.06.3834 |
0.549 |
|
| 2018 |
Ohlemacher SI, Xu Y, Kober DL, Malik M, Nix JC, Brett TJ, Henderson JP. YbtT is a low-specificity type II thioesterase that maintains production of the metallophore yersiniabactin in pathogenic enterobacteria. The Journal of Biological Chemistry. PMID 30355735 DOI: 10.1074/jbc.RA118.005752 |
0.585 |
|
| 2018 |
Berry KN, Kober DL, Su A, Brett TJ. Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST-2/Tetherin: Knowledge and Gaps. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. e1800086. PMID 30113067 DOI: 10.1002/Bies.201800086 |
0.563 |
|
| 2017 |
Kober DL, Brett TJ. TREM2-ligand interactions in health and disease. Journal of Molecular Biology. PMID 28432014 DOI: 10.1016/J.Jmb.2017.04.004 |
0.626 |
|
| 2016 |
Kober DL, Alexander-Brett JM, Karch CM, Cruchaga C, Colonna M, Holtzman MJ, Brett TJ. Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. Elife. 5. PMID 27995897 DOI: 10.7554/Elife.20391 |
0.65 |
|
| 2016 |
Yurtsever Z, Patel DA, Kober DL, Su A, Miller CA, Romero AG, Holtzman MJ, Brett TJ. First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. Biochimica Et Biophysica Acta. PMID 27369736 DOI: 10.1016/J.Bbagen.2016.06.023 |
0.646 |
|
| 2016 |
Kober DL, Alexander-Brett JM, Karch CM, Cruchaga C, Colonna M, Holtzman MJ, Brett TJ. Author response: Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms Elife. DOI: 10.7554/Elife.20391.021 |
0.6 |
|
| 2015 |
Kober DL, Yurtsever Z, Brett TJ. Efficient Mammalian Cell Expression and Single-step Purification of Extracellular Glycoproteins for Crystallization. Journal of Visualized Experiments : Jove. e53445. PMID 26780656 DOI: 10.3791/53445 |
0.647 |
|
| 2015 |
Wu K, Byers DE, Jin X, Agapov E, Alexander-Brett J, Patel AC, Cella M, Gilfilan S, Colonna M, Kober DL, Brett TJ, Holtzman MJ. TREM-2 promotes macrophage survival and lung disease after respiratory viral infection. The Journal of Experimental Medicine. 212: 681-97. PMID 25897174 DOI: 10.1084/Jem.20141732 |
0.598 |
|
| 2014 |
Kober DL, Wanhainen KM, Johnson BM, Randolph DT, Holtzman MJ, Brett TJ. Preparation, crystallization, and preliminary crystallographic analysis of wild-type and mutant human TREM-2 ectodomains linked to neurodegenerative and inflammatory diseases. Protein Expression and Purification. 96: 32-8. PMID 24508568 DOI: 10.1016/J.Pep.2014.01.015 |
0.662 |
|
| 2014 |
Kober D, Brett T. Structural Studies of TREM-2 Mutants Linked to Neurodegenerative Diseases Acta Crystallographica Section a Foundations and Advances. 70: C248-C248. DOI: 10.1107/S2053273314097514 |
0.669 |
|
| 2013 |
Combs MD, Knutsen RH, Broekelmann TJ, Toennies HM, Brett TJ, Miller CA, Kober DL, Craft CS, Atkinson JJ, Shipley JM, Trask BC, Mecham RP. Microfibril-associated glycoprotein 2 (MAGP2) loss of function has pleiotropic effects in vivo. The Journal of Biological Chemistry. 288: 28869-80. PMID 23963447 DOI: 10.1074/Jbc.M113.497727 |
0.588 |
|
| Show low-probability matches. |